Morrone Louis H.'s Form 4 filing
Abbott Laboratories (ABT) · filed Aug 13, 2026
- Accession no.
- 0001867666-26-000013
- Filed
- Aug 13, 2026, 5:14 PM ET
- Trade date
- Aug 11-12, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $642.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Morrone Louis H.CIK 0001867666 | Officer (EXECUTIVE VICE PRESIDENT) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Common shares without par value | SSaleDisposed | −5,850 | $109.83 | −$642,505.5 | 70,724 | Direct | |
| Aug 12, 2026 | Common shares without par value | ILess common codeDisposed | −12 | $107.99 | −$1,295.88 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.